abs119.txt	melanoma	is	the	most	aggressive	type	of	skin	cancer	in	united	states	with	anincreasing	incidence		lesions	often	exhibit	high	immunogenicity	withinfiltrating	immune	cells	playing	important	roles	regression	tumorsoccurring	spontaneously	or	caused	by	therapeutic	treatment	computational	andexperimental	methods	have	been	used	to	estimate	abundance	intumors	but	their	applications	are	limited	requirement	large	gene	setsor	multiple	antibodies	although	prognostic	role	has	beenappreciated	a	systematic	investigation	association	clinicalfactors	genomic	features	prognosis	and	response	stilllacking	this	study	identifies	25-gene	signature	based	on	rna-seq	data	fromthe	genome	atlas	(tcga)-skin	cutaneous	(tcga-skcm)	dataset	thissignature	was	calculate	sample-specific	leukocyte	infiltration	scores(lis)	six	independent	microarray	datasets	scores	were	found	tovary	substantially	between	different	lesion	sites	molecularsubtypes	for	metastatic	lis	all	highlis	being	associated	good	survival	current	approach	provided	additionalprognostic	information	over	established	clinical	factors	including	age	tumorstage	gender	addition	predictive	patient	stageiii	efficacy	tumor-specific	antigenvaccine	implications	that	effectivelyestimates	level	cell	which	provides	arobust	biomarker	predicting	mol	res	1-11	Â©2018aacr
